home / stock / prax / prax news


PRAX News and Press, Praxis Precision Medicines Inc. From 04/26/24

Stock Information

Company Name: Praxis Precision Medicines Inc.
Stock Symbol: PRAX
Market: NASDAQ
Website: praxismedicines.com

Menu

PRAX PRAX Quote PRAX Short PRAX News PRAX Articles PRAX Message Board
Get PRAX Alerts

News, Short Squeeze, Breakout and More Instantly...

PRAX - How the (PRAX) price action is used to our Advantage

2024-04-26 16:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PRAX - Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imb...

PRAX - (PRAX) Trading Report

2024-04-06 21:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PRAX - Praxis Precision Medicines to Participate in Upcoming April Conferences

BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imb...

PRAX - Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imb...

PRAX - (PRAX) Technical Pivots with Risk Controls

2024-03-27 21:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PRAX - Praxis Precision Medicines announces proposed public offering

2024-03-27 16:18:45 ET More on Praxis Precision Medicines Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing Praxis gains after mid-stage data for epilepsy candidate Biggest stock movers today: Hertz Global, Crypto-linked stocks, Southwestern Energ...

PRAX - VERI, CHEK and MESO are among pre market gainers

2024-03-27 08:24:20 ET More on premarket gainers & stock Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast gains as FDA backs regulatory plans fo...

PRAX - US Companies Moving the Markets, Evening edition
Tue, Mar 26, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 36.6% to $0.0481 on volume of 589,492,515 shares Nikola Corporation (NKLA) rose 9.5% to $0.8139 on volume of 120,009,646 shares Tesla Inc. (TSLA) rose 2.9% to $177.67 on volume of 112,332,335 shares Direxion Da...

PRAX - Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing

2024-03-26 13:34:38 ET Summary Praxis Precision Medicines, Inc. results from the phase 3 Essential3 program, using ulixacaltamide for the treatment of patients with essential tremor, expected in the 2nd half of 2024. Company believes that the essential tremor U.S. market opportuni...

Previous 10 Next 10